Published on
June 1, 2026
- 14:11 GMT
OneroRx Launches Lower-Cost Diabetes Medication Brenzavvy
WEST DES MOINES, IA, UNITED STATES, June 1, 2026 /EINPresswire.com/ -- OneroRx, a community-focused healthcare provider, announced the immediate availability of Brenzavvy (Bexagliflozin), a lower-cost SGLT2 inhibitor for adults with type 2 diabetes. …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
